Huxley Health Inc. Introduces Aerasyn Biotech Division, Expands Leadership and Scalable IP Platform, Engages Capital Partner for Up to $15M Financing and Prepares to Go Public Amid Growing U.S. Policy and Public Discourse on Psychedelics
Toronto, Ontario – Newsfile Corp. – April 20, 2026 – Huxley Health Inc. (“Huxley” or…

